1. Home
  2. MDXG vs EFC Comparison

MDXG vs EFC Comparison

Compare MDXG & EFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • EFC
  • Stock Information
  • Founded
  • MDXG 2006
  • EFC 2007
  • Country
  • MDXG United States
  • EFC United States
  • Employees
  • MDXG N/A
  • EFC N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • EFC Real Estate
  • Sector
  • MDXG Health Care
  • EFC Finance
  • Exchange
  • MDXG Nasdaq
  • EFC Nasdaq
  • Market Cap
  • MDXG 1.3B
  • EFC 1.1B
  • IPO Year
  • MDXG N/A
  • EFC 2010
  • Fundamental
  • Price
  • MDXG $7.98
  • EFC $13.10
  • Analyst Decision
  • MDXG Strong Buy
  • EFC Buy
  • Analyst Count
  • MDXG 5
  • EFC 5
  • Target Price
  • MDXG $12.00
  • EFC $13.69
  • AVG Volume (30 Days)
  • MDXG 518.6K
  • EFC 949.2K
  • Earning Date
  • MDXG 02-26-2025
  • EFC 02-27-2025
  • Dividend Yield
  • MDXG N/A
  • EFC 11.91%
  • EPS Growth
  • MDXG N/A
  • EFC 21.68
  • EPS
  • MDXG 0.52
  • EFC 1.32
  • Revenue
  • MDXG $342,804,000.00
  • EFC $290,293,000.00
  • Revenue This Year
  • MDXG $9.56
  • EFC N/A
  • Revenue Next Year
  • MDXG $9.19
  • EFC $26.40
  • P/E Ratio
  • MDXG $15.86
  • EFC $9.96
  • Revenue Growth
  • MDXG 10.93
  • EFC 12.72
  • 52 Week Low
  • MDXG $5.47
  • EFC $10.88
  • 52 Week High
  • MDXG $10.14
  • EFC $13.46
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 35.32
  • EFC 71.01
  • Support Level
  • MDXG $7.81
  • EFC $12.56
  • Resistance Level
  • MDXG $8.54
  • EFC $13.12
  • Average True Range (ATR)
  • MDXG 0.23
  • EFC 0.15
  • MACD
  • MDXG -0.05
  • EFC 0.04
  • Stochastic Oscillator
  • MDXG 18.09
  • EFC 85.28

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

Share on Social Networks: